Abstract

AbstractHomocysteic acid (HA) has been established as a pathogen in Alzheimer's disease (AD) in 3xTg-AD model mice. However, it is not established whether HA is involved in the AD pathogenesis in humans. We investigated the relationship between urinary HA levels and Mini-Mental State Examination (MMSE) scores in patients with AD (n = 110, normal =22, AD=88) and found a positive, statistically significant relationship between the two variables (r = 0.39, p =0.00003, n = 110). This relationship was stronger in females. (r = 0.47, p = 0.00008, n = 65 in females; r = 0.39, p = 0.02, n =45 in males). The difference in the urinary HA level between normal and AD females was statistically significant (normal:18.4 + 10.6vsAD: 9.1 + 7.2 mM,p<0.01), but this difference in males was not statistically significant. (normal:12.7 + 6 vs AD8.8 + 7.8). Smoking, hypertension, and diabetes mellitus decreased urinary HA excretion. On the basis of these results, we showed that HA is usually excreted into urine in humans and did not affect brain function in normal individuals. However, when urinary HA excretion was decreased, HA was shown to damage brain function, particularly cognitive ability. To confirm our hypothesis, that is, when urinary HA is suppressed to be excreted into urine, the blood HA level will increase, we examined the relationship between the urinary HA level and blood HA level in 19 patients. The result was shown that the negative statistically significant relationship between them was observed (r=-0.6, p=0.007, n=19). From this result, the uremic encephalopathy of HA toxicity was confirmed. However there remains the question of how the blood HA affected the brain's cognitive function. The direct effect of green tea leaves ingestion on HA level and MMSE score were also observed. Ingested green tea leaves decreased HA level in blood and concomitantly increased MMSE score, suggesting that blood HA could affect cognitive function. But How? Some papers showed that exogenous NMDA including HA disrupted the blood brain barrier and entered into the brain and affected the cognitive function to decrease MMSE score. These results indicate that human AD pathogenesis is influenced by HA, and that HA is a human pathogen in AD, indicating that the pathogenesis of AD is similar to that of uremic encephalopathy. Also, urinary HA can be used as a biomarker for Alzheimer's disease.

Highlights

  • Amyloid treatment in mice has been shown to be successful in recovering memory impairment [1,2]

  • These results indicate that human Alzheimer’s disease (AD) pathogenesis is influenced by homocysteic acid (HA), and that HA is a human pathogen in AD, indicating that the pathogenesis of AD is similar to that of uremic encephalopathy

  • Patients showed urinary HA excretion was suppressed and their blood HA level increased, which indicated that patients showed an uremic encephalopathy of HA toxicity

Read more

Summary

Introduction

Amyloid treatment in mice has been shown to be successful in recovering memory impairment [1,2]. Many human clinical trials on amyloid treatment for Alzheimer’s disease (AD) have failed recently[3]. This suggests that another pathogenic process must be active in humans. We have recently found that homocysteic acid (HA) is an AD pathogen in 3xTg-AD model mice (with APP, Presenilin and Tau genes) [4]. We investigated whether the pathogenic action of HA is observed in humans. The results showed that HA is a human AD pathogen as well

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call